Dover (DOV) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
21 Apr, 2026Executive summary
Fourth quarter 2025 delivered the highest organic growth rate of the year at 5%, with Q4 revenue up 9% to $2.1B and strong bookings momentum across all segments.
Full-year 2025 revenue reached $8.1B, up 4% all-in and 2% organically, with adjusted EPS up 16% to $9.61 and adjusted earnings from continuing operations up 15%.
Book-to-bill ratio was 1.02 in Q4, supporting continued demand into 2026.
Capital allocation included $700M in acquisitions and over $500M in share repurchases, maintaining balance sheet flexibility.
GAAP net income and EPS declined year-over-year due to a prior-year gain on the De-Sta-Co disposition.
Financial highlights
Q4 adjusted segment EBITDA margin was 24.8%, up 60 bps year-over-year; full-year margin was 25.1%, up 140 bps.
Free cash flow for 2025 was $1.12B (13.8% of revenue), up nearly $200M year-over-year; Q4 FCF was $487M (23% of revenue).
2025 capital spending increased by over $50M, focused on growth capacity and productivity investments; CapEx for 2025 was $220M (2.7% of revenue).
Reported earnings from continuing operations were $1.1B for the year, up 15% year-over-year.
Bookings for Q4 grew 10% year-over-year to $2.1B; full-year bookings rose 6% to $8.14B.
Outlook and guidance
2026 adjusted EPS guidance is $10.45–$10.65, representing double-digit growth at the midpoint; GAAP EPS expected at $8.95–$9.15.
2026 revenue growth projected at 5–7% all-in (3–5% organic); free cash flow expected at 14–16% of revenue.
Organic growth guidance for 2026 is 4%, with potential for upward revision as visibility improves.
Capex for 2026 guided at $190M–$210M; effective tax rate projected at 20–21%.
Management expects continued margin improvement from restructuring and productivity initiatives.
Latest events from Dover
- Q1 2026 delivered double-digit revenue and EPS growth, with strong bookings and robust demand.DOV
Q1 202623 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.DOV
Proxy filing24 Mar 2026 - Proxy covers director elections, auditor ratification, executive pay, and ESG progress.DOV
Proxy filing24 Mar 2026 - Strong growth, margin expansion, and balanced capital deployment support a positive outlook.DOV
JPMorgan Industrials Conference 202620 Mar 2026 - Strong Q4 orders and portfolio focus position the company for robust 2026 growth.DOV
Barclays 43rd Annual Industrial Select Conference17 Feb 2026 - Q2 2024 delivered 4–5% revenue growth, 15% EPS gain, and major portfolio moves.DOV
Q2 20242 Feb 2026 - Q3 earnings, margins, and bookings rose on portfolio actions and strong U.S. demand.DOV
Q3 202418 Jan 2026 - Margin expansion, portfolio optimization, and high-value segments drive 2025 growth outlook.DOV
Baird 2024 Global Industrials Conference14 Jan 2026 - 2025 outlook targets double-digit EPS growth on strong bookings, margin gains, and cash flow.DOV
Q4 20249 Jan 2026